研究方向
Human DcR3（Decoy Receptor 3）是一种可溶性受体，属于肿瘤坏死因子受体（TNFR）超家族成员。它通过结合特定的 TNF 家族配体（如 FasL、TL1A 和 LIGHT），调节免疫反应和细胞凋亡。以下是关于 Human DcR3 的详细信息：
1. 基本概述
2. 生物学作用
3. 研究与疾病关联
4. 治疗潜力
5. 最新研究进展
生物活性
Measured by its ability to inhibit Fas Ligand-induced apoptosis of Jurkat human acute T cell leukemia cells. The ED50 for this effect is 0.03‑0.15 µg/mL in the presence of 20 ng/mL rhFas Ligand.
Swiss Prot:
O95407
种属:
Human
表达宿主:
293F
表达区间:
Val 24-His300
实际分子量:
60-65 kDa
标签:
C-hFc&His tag
纯度：
>90% by SDS-PAGE.
内毒素：
＜0.1EU/ug of the protein by LAL method.
制剂：
Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.
描述：
Recombinant Human Human DcR3 Protein is produced by 293F expression system. The target protein is expressed with sequence (Val 24-His300) of Human Human DcR3 (Accession O95407) fused with a C-hFc&His tag.
储存：
Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.
未开盖的干粉蛋白在 -20°C至-80°C可保存12个月；
复溶之后，蛋白溶液在-20°C及以下可保存3个月，在2-8℃可保存1周。
复溶：
Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.
收到重组蛋白产品之后请检查蛋白冻干粉末是否贴于瓶底，如果粉末浮起，开盖之前请先低温离心。将蛋白用说明书中指定的缓冲液复溶至0.1-0.5 mg/mL（请注意蛋白复溶浓度不能低于0.1 mg/mL），室温平衡5-10 min保证充分溶解，复溶过程中请不要剧烈涡旋及吹打蛋白溶液。如需长期储存，建议复溶时添加载体蛋白或者稳定剂（如0.1% BSA, 5% HSA, 10% FBS 或者 5% 海藻糖），同时将复溶后的蛋白溶液按照需求进行分装，储存于-20°C至-80°C，随取随用，避免反复冻融。
